The ethics of gene therapy

Current Opinion in Molecular Therapeutics

Volumn 8, Issue 5, 2006, Pages 377-383

  Chan, Sarah ^a   Harris, John ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Embryo research; Enhancement; Ethics; Gene therapy; Genetic modification; Stem cells

Indexed keywords

DNA; LIPOSOME;

DNA MODIFICATION; EMBRYONIC STEM CELL; GENE TECHNOLOGY; GENE THERAPY; GENETIC MANIPULATION; GERM LINE GENE THERAPY; HUMAN GENOME; MEDICAL ETHICS; MEDICAL GENETICS; MEDICAL RESEARCH; MOLECULAR CLONING; MORALITY; NONVIRAL GENE DELIVERY SYSTEM; REVIEW; RISK ASSESSMENT; SOMATIC GENE THERAPY; STEM CELL TRANSPLANTATION; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

EMBRYO RESEARCH; GENE THERAPY; GENETIC ENGINEERING; GENETIC ENHANCEMENT; HUMANS;

EID: 33750006826     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Coutelle C, Thernis M, Waddington SN, Buckley SM, Gregory LG, Nivsarkar MS, David AL, Peebles D, Weisz B, Rodeck C: Gene therapy progress and prospects: Fetal gene therapy - first proofs of concept - some adverse effects. Gene Ther (2005) 12(22):1601-1607.
2. Smith KR: Gene therapy: Theoretical and bioethical concepts. Arch Med Res (2003) 34(4):247-268.
3. Saffery R, Choo KH: Strategies for engineering human chromosomes with therapeutic potential. J Gene Med (2002) 4(1):5-13.
4. Grimes BR, Monaco ZL: Artificial and engineered chromosomes: Developments and prospects for gone therapy. Chromosome (2005) 114(4):230-241.
5. Larin Z, Mejia JE: Advances in human artificial chromosome technology. Trends Genet (2002) 18(6):313-319.
6. Austin CP, Battey JF, Bradley A, Bucan M, Capecchi M, Collins FS, Dove WF, Duyk G, Dymecki S, Eppig JT, Grieder FB et al: The knockout mouse project. Nat Genet (2004) 36(9):921-924,
7. Capecchi MR: Altering the genome by homologous recombination. Science (1989) 244(4910):1288-1292.
8. Lakshmipathy U, Verfaillie C: Stem cell plasticity. Blood Rev (2005) 19(1):20-38.
9. Quesenberry PJ, Dooner G, Colvin G, Abedi M: Stem cell biology and the plasticity polemic. Exp Hematol (2005) 33(4):389-394.
10. Laflamme MA, Murry CE: Regenerating the heart. Nat Biotechnol (2005) 23(7):845-856.
11. Rice CM, Scolding NJ: Adult stem cells - reprogramming neurological repair? Lancet (2004) 364(9429):193-199.
12. Young HE, Duplaa C, Katz R, Thompson T, Hawkins KC, Boev AN, Henson NL, Heaton M, Sood R, Ashley D, Stout C et al: Adult-derived stem cells and their potential for use in tissue repair and molecular medicine. J Cell Mol Med (2005) 9(3):753-769.
13. Menendez P, Wang L, Bhatia M: Genetic manipulation of human embryonic stem cells: A system to study early human development and potential therapeutic applications. Curr Gene Ther (2005) 5(4):375-385.
14. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM: Embryonic stem cell lines derived from human blastocysts. Science (1998) 282(5391):1145-1147.
15. Reubinoff BE, Pera MF, Fong CY, Trounson A, Bongso A: Embryonic stem cell lines from human blastocysts: Somatic differentiation in vitro. Nat Biotechnol (2000) 18(4):399-404.
16. Pera MF: Human pluripotent stem cells: A program report. Curr Opin Genet Dev (2001) 11(5):595-599.
17. Hochedlinger K, Jaenisch R: Nuclear transplantation, embryonic stem cells, and the potential for cell therapy. N Engl J Med (2003) 349(3):275-286.
18. Jaenisch R: Human cloning - the science and ethics of nuclear transplantation. N Engl J Med (2004) 351(27):2787-2791.
19. Hwang WS, Ryu YJ, Park JH, Park ES, Lee EG, Koo JM, Jeon HY, Lee BC, Kang SK Kim SJ, Ahn C et al. Evidence of a pluripotent human embryonic stem cell line derived from a cloned blastocyst. Science (2004) 303(5664):1669-1674.
20. Hwang WS, Roh SI, Lee BC, Kang SK, Kwon DK, Kim S, Kim SJ, Park SW, Kwon HS, Lee CK, Kim JM et al: Patient-specific embryonic stem cells derived from human SCNT blastocysts. Science (2005) 308(5729):1777-1783.
21. Meissner A, Jaenisch R: Generation of nuclear transfer-derived pluripotent ES cells from cloned Cdx2-deficient blastocysts. Nature (2006) 439(7073):212-215.
22. Kennedy D: Editorial retraction. Science (2006) 311(5759):335.
23. Holm S: Going to the roots of the stem cell controversy. Bioethics (2002) 16(6):493-507.
24. Doerflinger RM: The ethics of funding embryonic stem cell research: A Catholic viewpoint. Kennedy Inst Ethics J (1999) 9(2):137-150.
25. Harris J: The concept of the person and the value of life. Kennedy Inst Ethics J (1999) 9(4):293-308.
26. Robertson JA: Ethics and policy in embryonic stem cell research. Kennedy Inst Ethics J (1999) 9(2):109-136.
27. Bortolotti L, Harris J: Embryos and eagles: Symbolic value in research and reproduction. Cambridge Quarterly Healthcare Ethics (2006) 15(1):22-34.
28. Bortolotti L, Harris J: Stem cell research, personhood and sentience. Reprod Biomed Online (2005) 10(Suppl 1):68-75.
29. Savulescu J: The embryonic stem cell lottery and the cannibalization of human beings. Bioethics (2002) 16(6):508-529.
30. Klimanskaya I, Chung Y, Becker S, Lu SJ, Lanza R: Human embryonic stem cell lines derived from single blastomeres. Nature (2006): DOI: 10:1038/ nature05142.
31. Kogler G, Sensken S, Airey JA, Trapp T, Muschen M, Feldhahn N, Liedtke S, Sorg RV, Fischer J, Rosenbaum C, Greschat S et al: A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med (2004) 200(2):123-135.
32. Takahashi K, Yamanaka S: Induction of pluripatent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 126(4):663-676.
33. Wolbert W. The potentiality argument in the debate relating to the beginning of personhood. Hum Reprod Genet Ethics (2000) 6(2):19-26.
34. Harris J (Ed): The Value of Life. Routledge & Keegan Paul, New York, NY, USA (1985).
35. Stanton C, Harris J: The moral status of the embryo post-Dolly. J Med Ethics (2005) 31(4):221-225.
36. Marquis D: A defence of the potential future of value theory. J Med Ethics (2002) 28(3):198-201.
37. Marquis D: Savulescu's objections to the future of value argument. J Med Ethics (2005) 31(2):119-122.
38. Savulescu J: Abortion, embryo destruction and the future of value argument. J Med Ethics (2002) 28(3):133-135.
39. Cameron C, Wiliamson R: In the world of Dolly, when does a human embryo acquire respect? J Med Ethics (2005) 31(4):215-220.
40. Hurlbut WB: Altered nuclear transfer as a morally acceptable means for the procurement of human embryonic stem cells. Perspect Biol Med (2005) 48(2):211-228.
41. Devolder K: What's in a name? Embryos, entities, and ANTities in the stem cell debate. J Med Ethics (2006) 32(1):43-48.
42. Devolder K: Human embryonic stem cell research: Why the discarded-created-distinction cannot be based on the potentiality argument Bioethics (2005) 19(2):167-186.
43. Devolder K: Creating and sacrificing embryos for stem cells. J Med Ethics (2005) 31(6):366-370.
44. Harris J: Stem cells, sex, and procreation. Cambridge Quarterly Healthcare Ethics (2003) 12(4):353-371.
45. Harris J: Sexual reproduction is a survival lottery. Cambridge Quarterty Healthcare Ethics (2004) 13(1):75-89.
46. Savulescu J, Harris J: The creation lottery: Final lessons from natural reproduction: Why those who accept natural reproduction should accept cloning and other Frankenstein reproductive technologies. Cambridge Quarterly Healthcare Ethics (2004) 13(1):90-95.
47. Savulescu J: Embryo research: Are there any lessons from natural reproduction? Cambridge Quarterly Healthcare Ethics (2004) 13(1):68-75.
48. Bukovsky A, Svetlikova M, Caudle MR: Oogenesis in cultures derived from adult human ovaries. Reprod Biol Endocrinol (2005) 3(1):17.
49. Testa G, Harris J: Genetics. Ethical aspects of ES cell-derived gametes. Science (2004) 305(5691):1719.
50. Testa G, Harris J: Ethics and synthetic gametes. Bioethics (2005) 19(2):146-166.
51. Harris J (Ed): Wonderwoman and Superman: The Ethics of Human Biotechnology. Oxford University Press, Oxford, UK (1992).
52. Billings PR, Hubbard R, Newman SA: Human germline gene modification: A dissent. Lancet (1999) 363(9167):1873-1875.
53. Adams H: A human germline modification scale. J Law Med Ethics (2004) 32(1):164-173.
54. Universal declaration on the human genome and human rights: Office of the United Nations High Commissioner for Human Rights, Geneva, Switzerland (1997). http://www.ohchr.org/english/law/genome.htm
55. Glannon W. Extending the human life span. J Med Philos (2002) 27(3):339-354.
56. Harris J, Holm S: Extending human lifespan and the precautionary paradox. J Med Philos (2002) 27(3):355-368.
57. Launis V: Human gene therapy and the slippery slope argument. Med Healthcare Philos (2002) 5(2):169-179.
58. Bourse C: On the distinction between disease and Illness. Philos Public Affairs (1975) 5:49-68.
59. Chan S, Harris J: In support of enhancement. Theor Med Bioethics (2006):in press.
60. Sandel MJ: The case against perfection: Whats wrong with designer children, bionic athletes, and genetic engineering. Atl Mon (2004) 292(3):50-54.
61. Baylis F, Robert JS: The inevitability of genetic enhancement technologies. Bioethics (2004) 18(1):1-26.
62. Savulescu J: New breeds of humans: The moral obligation to enhance. Reprod Biomed Online (2005) 10(Suppl 1):36-39.
63. Gillam L: Prenatal diagnosis and discrimination against the disabled. J Med Ethics (1999) 25(2):163-171.
64. Harris J: One principle and three fallacies of disability studies. J Med Ethics (2001) 27(6):383-387.
65. Murphy TF: Gay science: Assisted reproductive technologies and the sexual orientation of children. Reprod Biomed Online (2005) 10(Suppl 1):102-106.
66. Savulescu J: Harm, ethics committees and the gone therapy death. J Med Ethics (2001) 27(3):148-150.
67. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, Gross F, Yvon E, Nusbaum P, Setz F, Hue C, Certain S, Casanova JL, Bousso P et al: Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science (2000) 288(5466):669-672.
68. Marshall E: Clinical research. Gene therapy a suspect in leukemia-like disease. Science (2002) 298(5591):34-35.
69. Marshall E: Gene therapy. Second child in French trial is found to have leukemia. Science (2003) 299(5605):320.
70. Kimmelman J: Recent developments in gene transfer: Risk and ethics. Br Med J (2005) 330(7482):79-82.
71. Harris J: Scientific research is a moral duty. J Med Ethics (2005) 31(4):242-248.
72. Harris J, Holm S: Should we presume moral turpitude in our children? - small children and consent to medical research. Theor Med Bioeth (2003) 24(2):121-129.
73. Cornford FM (Ed): Microcosmographia Academica. Bowes and Bowes, London, UK (1908).